in Newswire Published on June 16, 2020

COVID-19 Test Maker Hit with Investor’s Class Action Over ‘100% Accurate’ Claim

Gelt Trading, Ltd. v. Co-Diagnostics, Inc. et al.

Filed: June 15, 2020 § 2:20-cv-00368

A class action alleges Co-Diagnostics, Inc. caused investors to lose millions when the FDA contradicted the company’s “100% accuracy” claims for its COVID-19 tests.

Defendant(s)

Co-Diagnostics, Inc.

State(s)

Utah

Categories

Securities COVID-19

Case Spotlight

Hair Relaxer Lawsuits

How Do I Join a Class Action Lawsuit?

ClassAction.org Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Last Updated on June 16, 2020 — 5:08 PM

Erin Shaak

erin@classaction.org

Erin works primarily on ClassAction.org’s newswire, reporting on cases as they happen.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.